Deep Genomics

In the first of a new series, we ask: #WhyAI? At Deep Genomics, we are pioneering new AI science alongside biological science. But what are some key challenges facing biotech and pharmaceutical industries that foundation models can help solve? While the current climate for biopharma innovation is seemingly ideal, productivity remains low. @The National Institutes of Health in the United States highlighted that of 16 leading pharma companies, R&D spending increased at a compound annual growth rate of 6% between 2001-2020. This led to an average R&D expenditure per company of $6.7 billion - and nearly half had negative productivity as a result. Standard AI has not yet lived up to the promise of increased productivity, but AI foundation models, such as BigRNA, offer a new approach. BigRNA can uniquely discover - at speed - a wide range of new targets and RNA therapeutic opportunities that otherwise would take too much money and workforce power to find. Want to learn more about BigRNA and “Why AI”? Learn more on the Deep Genomics website: https://lnkd.in/gP4apMmb #BigRNA #techbio #biotech #aipharma

Excited to share a new series here on our LinkedIn. We’re highlighting members of the Deep Genomics team - and who better to start this series than our founder and CIO, Brendan Frey! Read more about Brendan’s background, including his previously published work and papers, and his work at University of Toronto. Learn more about Deep Genomics, and find out more about how to join our team, at https://lnkd.in/d8fB4GZ. #deepgenomics #teamspotlight #toronto #bosto

We’re pleased to share this insightful article by our founder, Brendan Frey, now live on the Healthcare Business Today website. Brendan’s article highlights the transformative power of AI foundation models in pharmaceutical R&D that we’re seeing every day in our work. The pharmaceutical industry is moving away from an approach where AI is task-driven into foundation models. But how can they use them effectively? Read Brendan’s full article below to leverage AI foundation models for positive and impactful change in the industry. #deepgenomics #techbio #aipharma #pharmaindustry #foundationmodels

It was great to have our Vice President and Head of Machine Learning, Joel Shor, at Google Cloud’s Startup GenAI Roundtable this week. The session delved into how businesses can leverage AI for innovation and the pressing ethical considerations of AI - areas that we, at Deep Genomics, are deeply committed to. For example, AI has enabled us to move from statistical analysis to making predictions. But one of our key priorities now is verifying these predictions and connecting the dots between analytical predictions and biological validation. Our industry is high stakes, so we need to be sure that we can trust the outputs of our models. Take a look at some of the photos from the day below. Thanks again to the Google Cloud team for inviting us, and we’re looking forward to working closely together in the future! #googlecloud #deepgenomics #genai #aiethics #aiinnovation

We’re excited to announce a number of new key leadership hires at Deep Genomics, as part of our continuing growth and expansion. Those joining us are: ✅ Radu Dobrin as Chief Technology Officer ✅ Greg Hoffman as Chief Scientific Officer ✅ Joel Shor as Vice President and Head of Machine Learning ✅ Clive Bertram as Chief Business Officer All four of our new senior hires bring years of expertise in the field to Deep Genomics. They will undoubtedly be vital in helping us continue to deliver on our exciting new path to genomic R&D. Deep Genomics’ Founder and CIO, Dr. Brendan Frey, says: "We are thrilled to welcome these exceptional leaders to the Deep Genomics team. Their collective expertise will propel our efforts to revolutionize genomic R&D and accelerate the development of life-changing therapeutics." You can learn more about each of our new hires and their background through the press release, available on the Deep Genomics website below. Please join us in warmly welcoming Radu, Greg, Joel, and Clive to the Deep Genomics team! 👋 #deepgenomics #expansion #leadershipteam #techbio

We’re pleased to announce that Deep Genomics will be at #BIO2024 throughout next week (Jun 3-6) Biotechnology Innovation Organization. Our founder and CIO, Brendan Frey, will be on stage on June 5th at 12:15 as part of the event. Brendan will be in Company Presentation Theater 4 to talk about Deep Genomics, our mission, and our groundbreaking progress with our BigRNA model. BIO 2024 promises to be the largest and most comprehensive event for biotechnology, bringing together over 18,000 industry leaders from across the world. We look forward to meeting many of you at the event. To schedule time with us, click here: https://lnkd.in/gR3S4AfD Let us know below in the comments if you plan to attend.

In light of this week's news with Google, we want to highlight some of our other recent success stories - including our Founder and CIO, Brendan Frey, being named by Business Insider as one of the top 10 people in AI Healthcare. Brendan has made fundamental contributions in the fields of deep learning, genomic medicine, and information technology. As the article notes, Brendan pioneered the development of AI systems that could accurately predict normal and pathological cell and genome biology, facilitating biomedical breakthroughs. He has authored over 200 papers on machine learning and genome biology. Today, he leads our team’s innovative approach to genomic R&D. Thank you Samantha Stokes! #AIHealthcare

What an incredible era for AI and R&D! We are delighted to be highlighted by Google today as “powering the future of drug discovery with AI” alongside the company’s huge step forward with the new Trillium TPU. With amplified computing power like Trillium, our Foundation Model BigRNA will be able to propel advancements in pharma even faster, powering Deep Genomics and our partners to bring life changing medicines to patients. It’s another great sign of how AI technology and scientific advancements are colliding to change the future for RNA R&D. #BigRNA #Trillium #RNA Google Cloud

We are hiring! We are looking for a Senior Machine Learning Scientist (ML) - Accelerating Drug Discovery with AI Please visit for more info and to apply https://lnkd.in/g_uP6Zjv

We are hiring! We are looking for a Senior Machine Learning Operations Engineer (ML Ops) - Accelerating Drug Discovery with AI! Please visit for more info and to apply https://lnkd.in/gwrpwJvG